Intelligence · Clinical Pipeline
Nanjing Legend Biotech Pipeline
All ClinicalTrials.gov programs at Nanjing Legend Biotech — phase, modality, and trial IDs.
- Programs
- 2
Quick answer
Nanjing Legend Biotech has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
LCAR-B38M CAR-T Cell
Nanjing Legend Biotech Co.
Multiple Myeloma
1 trial -
LCAR-B38M CAR-T cell injection
Nanjing Legend Biotech Co.
Refractory or Relapsed Multiple Myeloma
1 trial
Frequently asked questions
How many pipeline programs does Nanjing Legend Biotech have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs